CME in Minutes: Education in Cardiology & Pulmonology

By Answers in CME

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.

Image by Answers in CME

Category: Life Sciences

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast

Subscribers: 7
Reviews: 0
Episodes: 70

Description

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Cardiology & Pulmonology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for busy healthcare professionals to cover the diagnosis, treatment, follow-up, and clinical management of conditions in cardiology, pulmonology. Earning your CME/CE credit has never been faster or easier. Download the URL for each individual program to request continuing education credit or access the slides.

Episode Date
Taofeek K. Owonikoko, MD, PhD, MS / Ticiana Leal, MD - New Frontiers in Small Cell Lung Cancer: Getting Ready for the Emergence of B7-H3–Directed ADCs
Dec 12, 2025
Nicola Hanania, MD, MS / Surya P. Bhatt, MD, MSPH - Demystifying the Evidence for Biologics in COPD: Strategies for Optimized, Patient-Centered Management
Dec 11, 2025
Mark Awad, MD, PhD / Carl M. Gay, MD, PhD - Breaking News in Small-Cell Lung Cancer: Expert Insights on B7-H3–Directed Antibody–Drug Conjugates From Recent Congresses
Dec 01, 2025
Luis Paz-Ares, MD, PhD / Lauren Averett Byers, MD - Shaping the Future of SCLC Treatment: Advancing Care Through Innovative Approaches
Nov 24, 2025
Anne K. Ellis, MD, MSc, FRCPC / Andrew Thamboo, MD, FRCSC / Meyer Balter, MD, FRCPC - Advancing CRSwNP Care: Multidisciplinary Insights on Early Detection and the Role of Biologic Therapies
Nov 21, 2025
Luis Paz-Ares, MD, PhD / Kristin Higgins, MD - Creating a Roadmap to Optimize Care for Patients With LS-SCLC: Integrating the Evidence Into Practical Care
Oct 30, 2025
MeiLan Han, MD, MS / Eddie Needham, MD, FAAFP / Valerie Chang - COPD Primary Care Playbook: Boosting Diagnosis, Treatment, and Therapy Escalation for Optimal Disease Control
Oct 17, 2025
Stephanie Christenson, MD, MAS - Beyond Standard Care: Enhancing Disease Control With Biologic Therapy for Eosinophilic COPD
Sep 24, 2025
Raffaele Califano, MD / Nicolas Girard, MD, PhD / Antonio Passaro, MD, PhD - Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes
Sep 10, 2025
Matthew W. Martinez, MD, FACC, FASE / Brad Mehl, MHA, ACS, RDCS, RVT, RDMS, RT(R), FASE - The Echo Quest: Conquering Real-World Hypertrophic Cardiomyopathy Cases From Diagnosis to Treatment
Sep 09, 2025
Scott Solomon, MD - Mapping the Future of Heart Failure Care: The Evolving Role of Nonsteroidal MRAs in the Treatment of Patients With Heart Failure and Mildly Reduced/Preserved Ejection Fraction
Sep 01, 2025
Luis Paz-Ares, MD, PhD / Niels Reinmuth, MD, PhD - Developing a Master Plan for ES-SCLC: A Practical Guide to Elevate Care in the Real-World
Jul 28, 2025
Barbara Burtness, MD - The Pan-Tumor Perspective: Looking Toward the Future of Care With HER3-Directed ADCs for Pretreated Patients With Advanced Solid Tumors
Jul 01, 2025
Mark A. Socinski, MD - Global Perspectives on Biomarker Testing in NSCLC: Clinical Insights on Optimizing Implementation in Practice
Jun 24, 2025
David E. Griffith, MD - Guiding Principles in the Management of Refractory Mycobacterium Avium Complex (MAC) Pulmonary Disease: Casing the Evidence to Inform Practical Care
Apr 07, 2025
Jai Radhakrishnan, MD, MS - IgA Nephropathy in Focus: Novel Treatment Strategies for Nephrologists and PCPs
Jan 03, 2025
Pasi A. Jänne, MD, PhD - Expanding Pathways of Care for HER2-Positive Metastatic NSCLC: Beyond Mutation to Overexpression
Jan 02, 2025
Arzu Yorgancioglu, MD - A Global Approach to Asthma Management: Examining Biologics
Jan 02, 2025
Stella Lee, MD - Biologic Therapies for Chronic Rhinosinusitis With Nasal Polyps: Practical, Patient-Centered Perspectives for Providers
Dec 12, 2024
David Harpole, MD / Alfredo Addeo, MD - The Possibilities of Perioperative: Assessing the Use of Perioperative Immunotherapy for Resectable NSCLC
Dec 12, 2024
Csaba P. Kovesdy, MD - Integrating Nonsteroidal MRAs in Practice: A Guideline-Driven Approach to the Management of CKD and T2D
Nov 29, 2024
David Harpole, MD / Neel Chudgar, MD - The Practicalities of Perioperative Immunotherapy for Resectable NSCLC
Nov 26, 2024
David Harpole, MD / Nicolas Girard, MD, PhD - Trials and Tribulations: Examining the Data for Perioperative Immunotherapeutic Approaches in Resectable NSCLC
Nov 20, 2024
Stephanie A. Christenson, MD, MAS - ​Targeting Eosinophils for Fewer Exacerbations:​ The Future of Biologic Treatments in COPD Management
Sep 20, 2024
Mark Awad, MD, PhD - Advancing the Therapeutic Landscape of SCLC with B7-H3–Targeted Antibody-Drug Conjugates: Insights and Future Directions
Sep 09, 2024
Leonard B. Bacharier, MD - Highlighting the Use of Biologics in Pediatric Patients: Case Scenarios to Elevate Asthma Treatment
Sep 09, 2024
Cecelia Damask, DO - Evidence-Based Approaches to Sequencing and Switching Biologic Therapies in Patients With CRSwNP and Comorbidities
Aug 16, 2024
Theresa W. Guilbert, MD, MS / William Anderson, MD - Optimizing Asthma Care in Pediatrics: The Impact of Early Intervention With Biologics on Lung Function
Aug 16, 2024
Eileen Wang, MD, MPH - Breathing Life Into Type 2 Asthma: Advancing Clinical Remission With Biologics
Aug 05, 2024
Luis Paz-Ares, MD, PhD - Exploring the Potential of TROP2 ADCs for Advanced/Metastatic NSCLC: Implications for Practice
Jul 12, 2024
Michael Thorpy, MD - Narcolepsy and Cardiovascular Health: Real-World Strategies to Enhance Long-Term Patient Outcomes
Jun 25, 2024
George L. Bakris, MD - On the Path to Improved Outcomes in Cardiorenal Disease: Strategies to Address Hyperkalemia and Maintain RAASi Therapy
Jun 18, 2024
Richard Bernstein, MD, PhD - Factoring a Balanced Efficacy and Safety Profile Into the Equation: Exploring FXIa Inhibitors in Stroke Prevention
Jun 18, 2024
Nick H. Kim, MD - Multimodal Management of Inoperable CTEPH: Evolving Therapeutic Strategies
May 15, 2024
Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician
Apr 05, 2024
Peter Lio, MD - Generative AI: Benefits for Your Practice, for Your Patients
Apr 05, 2024
Iacopo Olivotto, MD - A New Chapter in Hypertrophic Cardiomyopathy Management: Updates From the European Society of Cardiology (ESC) 2023 Guidelines and New Treatment Options
Mar 25, 2024
Heather Wakelee, MD - Stepping Up Clinical Outcomes for Resectable NSCLC: Examining the Role of Neoadjuvant Plus Adjuvant Immunotherapy Regimens
Mar 14, 2024
Vallerie V. McLaughlin, MD - Adding On Potential: Improving Treatment of Pulmonary Arterial Hypertension With Novel Add-On Therapies
Feb 26, 2024
Nicola A. Hanania, MD, MS - Enough: Targeting Eosinophilic Pathways With Biologics in Chronic Obstructive Pulmonary Disease
Jan 12, 2024
Michael Wechsler, MD - On the Case to Improve Outcomes in Uncontrolled Asthma: Best Practices to Enhance Clinical Care
Dec 29, 2023
Patrick Forde, MB, BCh - Keeping the Dialogue Open in Early-Stage NSCLC: Instituting a Multidisciplinary Approach
Dec 18, 2023
Jennifer Hill, MD - Breathing New Air Into Improved Outcomes: Strategies to Optimize Care in Patients With Uncontrolled Asthma
Dec 05, 2023
Vallerie V. McLaughlin, MD - Goal-Directed Therapy in PAH: Using Guideline-Recommended Sequential Combination Therapy Based on Risk Stratification to Optimize Patient Outcomes
Nov 13, 2023
Pam R. Taub, MD, FACC - Making the Case for Novel LDL-C–Lowering Therapies in the Management of Pediatric and Adult Homozygous Familial Hypercholesterolemia
Oct 09, 2023
Christopher P. Cannon, MD / Geetha Raghuveer, MD, MPH, MRCP - The Cholesterol Conversation: Early and Intensive Treatment of Homozygous Familial Hypercholesterolemia With Novel LDL-Lowering Strategies
Sep 19, 2023
Eric K. Singhi, MD / Charu Aggarwal, MD, MPH - It Takes Two to Tango: Exploring the Clinical Implications of First-Line Immunotherapy Plus Chemotherapy Combinations in Advanced NSCLC
Sep 05, 2023
Alexander I. Spira, MD, PhD, FACP - Breaking News in NSCLC: The Latest Evidence on Emerging Antibody Drug Conjugates Targeting TROP2
Sep 05, 2023
Jeffrey B. Geske, MD / Anjali Tiku Owens, MD - Expert Cardiology Perspectives in HCM: Slowing Disease Progression With Early Diagnosis and Integration of Cardiac Myosin Inhibitors
Aug 29, 2023
Jamie E. Chaft, MD - Enhancing Outcomes for Patients With Resected, Early-Stage NSCLC: A Piercing Evaluation of the Clinical Support for Adjuvant Immunotherapies
Aug 23, 2023
Bradley Chipps, MD - Calling the Shots for Pediatric Asthma Control: Integrating Biologics Into the Treatment Plan to Enhance Outcomes
Aug 17, 2023
Enriqueta Felip, MD, PhD / David Harpole, MD - Reflecting on the Role of Perioperative Immunotherapeutic Regimens for Resectable Non–Small-Cell Lung Cancer: Evaluating the Evidence to Determine Better Pathways of Care
Jul 27, 2023
Ticiana Leal, MD - Inspiring Improved Outcomes in Advanced NSCLC: A Patient-Centered Approach to Integrating Combination Locoregional and Immunotherapy Into Care
Jul 03, 2023
Kamala P. Tamirisa, MD, FACC, FHRS - Striving Toward Health Equity in Cardiovascular Disease: Patient-Centered Conversations to Address Social Determinants of Health in Nonvalvular Atrial Fibrillation
Apr 10, 2023
Pantelis Sarafidis, MD, MSc, PhD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists Early in the Course of Disease: Practical Strategies for Patients With Early-Stage CKD and T2D
Mar 30, 2023
Giovanni L. Ceresoli - Advancing Care in Advanced Non–Small-Cell Lung Cancer With Combination Locoregional and Systemic Therapies
Mar 30, 2023
George L. Bakris, MD, MA / Paul P. Doghramji, MD, FAAFP - Enhancing Patient Outcomes in CKD: Recognizing the Importance of Early Detection and Optimized Management
Mar 27, 2023
Nicolas Girard, MD, PhD - Fortifying Outcomes in Unresectable Stage III Non–Small-Cell Lung Cancer: Current and Evolving Strategies to Optimize the Use of Consolidation Immunotherapy
Feb 15, 2023
Enriqueta Felip, MD, PhD - Breaking News for Frontline Dual Immunotherapy and Chemotherapy Combination Regimens: Improving Patient Outcomes in Advanced NSCLC
Jan 09, 2023
Nicola A. Hanania, MD, MS - Breathing With Ease in COPD: Patient-Centric Strategies to Improve Outcomes and Adherence With Triple Inhaler Therapy
Dec 29, 2022
Jennifer Green, MD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With CKD and T2D: Novel Strategies to Minimize Progression in Patients With Advanced Disease
Dec 29, 2022
Anne O'Donnell, MD - Diagnostic Imaging in Non-Cystic Fibrosis Bronchiectasis: The Radiologist's Role in Optimizing Care
Dec 29, 2022
Christoph Wanner, MD - Bringing the Treatment of Patients With CKD and T2D up to Speed: Synthesizing Guideline Updates and the Latest Data for Non-Steroidal Mineralocorticoid Receptor Antagonists
Dec 13, 2022
Theresa W. Guilbert, MD, MS - Blazing a Trail to Enhanced Outcomes for Children with Moderate-to-Severe Asthma: Practical Strategies to Incorporate Biologics
Dec 02, 2022
Matteo Bonini, MD, PhD - Maximizing Outcomes With Biologics: Gaining Control Over Uncontrolled Moderate-to-Severe Asthma in Children
Dec 02, 2022
Sandy Durrani, MD - Enhancing Control, Maximizing Outcomes: Advancements in Care for Children With Inadequately Controlled Asthma
Nov 28, 2022
Christopher P. Cannon, MD - On the Case to Reduce the Cumulative Burden of Elevated LDL-C in Patients With Severe Familial Hypercholesterolemia
Nov 15, 2022
LJ Tan, MS, PhD - RSV Vaccines in Older Adults: Emerging Prevention Strategies
Oct 28, 2022
Robert S. Rosenson, MD - Taking to Heart the Cumulative Burden of Elevated LDL Cholesterol: Clinical Strategies to Enhance Outcomes in Severe Familial Hypercholesterolemia
Oct 27, 2022
Mary O'Brien, MD, FRCP - Moving Immune Checkpoint Inhibitors to Resected Early-Stage Non-Small Cell Lung Cancer: Emerging Strategies for Adjuvant Therapy
Aug 12, 2022